How ISPOR Activity Rankings Influence Health‑Economics Research

When scholars look for reliable benchmarks in pharmacoeconomics, the ISPOR activity ranking often surfaces as a go‑to reference. This informal yet widely consulted list grades conferences, publications, and collaborative projects based on criteria such as citation impact, stakeholder engagement, and methodological rigor. Understanding how these rankings are compiled—and what they actually mean for researchers—can help you decide where to submit your work, which networks to join, and how to position your findings for maximum relevance.

Why Do ISPOR Rankings Matter?

ISPOR (the International Society for Pharmacoeconomics and Outcomes Research) serves as a hub for clinicians, economists, and policy makers. Its activity rankings act like a compass, pointing professionals toward events and outputs that are most likely to shape policy and practice. Because funding bodies and academic promotion committees increasingly look for evidence of impact, a high ranking can translate into better grant prospects and stronger CV entries.

How the Rankings Are Constructed

There isn’t a single, official methodology published by ISPOR. Instead, a consortium of academic volunteers and industry analysts collates data from multiple sources:

• Citation metrics. Databases such as Scopus and Web of Science provide citation counts for papers presented at ISPOR conferences or published in its journals.
• Attendance and diversity. Organizers track registration numbers, geographic spread, and the mix of sectors represented (e.g., pharma, payers, academia).
• Stakeholder feedback. Post‑event surveys capture perceived relevance, practical applicability, and satisfaction among participants.
• Policy uptake. Researchers monitor how often conference findings are cited in health‑technology‑assessment reports or national guidelines.

Each factor receives a weight that reflects its perceived importance to the field. The weighted scores are then normalized, producing a rank order that changes annually as new data flow in.

Key Insights From Recent Analyses

Several independent studies have examined the stability and predictive value of the ISPOR rankings. A recurring theme is that higher‑ranked activities tend to attract more interdisciplinary collaborations. For example, the 2022 ISPOR Europe conference—consistently placed in the top tier—saw a 30 % rise in joint publications between health‑economists and real‑world evidence analysts compared with the previous year. Moreover, papers emerging from top‑ranked workshops are more likely to be referenced in payer decision‑making documents within 12‑18 months.

Conversely, some lower‑ranked events excel in niche areas, such as rare‑disease cost‑effectiveness modeling. Researchers interested in these specialized topics often report that the “underdog” sessions provide more hands‑on training than the marquee sessions, which can be more theoretical.

Practical Takeaways for Researchers

If you’re planning your next submission, consider these points:

• Align your study with the ranking’s strengths. A robust health‑technology‑assessment (HTA) model fits well with top‑ranked conferences that emphasize policy translation.
• Leverage networking opportunities. High‑ranking events usually host industry panels where you can meet potential funders.
• Don’t overlook specialty sessions. Even a modestly ranked workshop can provide targeted feedback that improves methodological soundness.
• Document impact early. Keep track of citations and policy mentions to bolster your CV when the rankings are later referenced.

Critiques and Limitations

While the rankings are useful, they are not without flaws. The weighting system, for instance, can over‑value citation counts, which may favor topics that are already popular rather than emerging ones. Additionally, attendance figures can be skewed by promotional discounts or travel grants, inflating the perceived reach of an event.

Another point of contention is the reliance on self‑reported surveys. Respondents who had a positive experience are more likely to complete feedback forms, potentially biasing the satisfaction scores upward.

Where the Rankings Are Headed

Recent discussions within the ISPOR community suggest a shift toward more transparent and granular metrics. Proposals include incorporating alt‑metric scores—social media mentions, policy brief downloads—and offering separate rankings for methodological innovation versus policy impact. Such refinements could help researchers pinpoint exactly which activities align with their career goals.

Frequently Asked Questions

What does a high ISPOR ranking actually guarantee?

It signals strong visibility and a track record of influencing policy, but it doesn’t guarantee publication acceptance or funding. Success still depends on the quality of your work and how well it matches the event’s focus.

Can I improve my institution’s ranking by encouraging staff to attend ISPOR events?

Yes, collective participation can boost attendance metrics, which feed into the ranking algorithm. However, genuine engagement—such as presenting research or contributing to panels—carries more weight than mere presence.

Are there alternatives to ISPOR rankings for assessing impact?

Alternative measures include citation‑based journal impact factors, the number of HTA submissions influenced by your work, and direct feedback from payer agencies. Using a combination of these metrics provides a fuller picture of influence.